Coronavirus Update: Moderna Hold Up, Sanofi and Regeneron's Kevzara Fails In Phase III
IL-6 Drugs Down But Not Out
Delay to Moderna's Phase III plans adds to the biotech's rollercoaster ride, but its CEO insists it is still on track.
Delay to Moderna's Phase III plans adds to the biotech's rollercoaster ride, but its CEO insists it is still on track.